Society of Surgical Oncology News - January/February 2017

SSO News 2017-1


IN THIS ISSUE

SSO Endorses Manuscript on Improving the Evidence Base for Cancer Treatment Modalities SSO Partners with Health Volunteers Overseas
SSO 2017 – Register by February 27 for Savings SSO 2017 Pre-Meetings Offer a Deeper Dive
SSO, BSSO and ESSO Release International Educational Video 2017 Regional Cancer Therapies Symposium Featured Recent Therapy Advances
SSO 2017-18 Election Results Announced SSO Membership Growth Sets New Record
SSO Foundation Supports Surgical Oncology Research and Education SSO Programs Offer Complimentary CME/MOC Credit
More Free CME Available by Viewing the DCIS Archived Webinar  

SSO Endorses Manuscript on Improving the Evidence Base for Cancer Treatment Modalities

The SSO Executive Council voted to endorse the joint statement on Improving the Evidence Base for Cancer Treatment Modalities. This joint statement aims to identify the main factors contributing to differences in evidence development across cancer treatment modalities and to provide consensus recommendations to strengthen the evidence base supporting innovations in cancer care.

The manuscript was developed by the Comparative Effectiveness Work Group established by the American Society of Clinical Oncology (ASCO). George Chan, MD, represented SSO on the panel. ASCO and SSO were joined by the American College of Surgeons, American Society for Radiation Oncology, and the Society of Interventional Radiology in developing the joint statement.

Share this story:      

SSO Partners with Health Volunteers Overseas

As part of SSO's ongoing efforts to expand its global outreach and fulfill its mission of improving multidisciplinary patient care by advancing the science, education and practice of cancer surgery worldwide, SSO has become a sponsoring organization of Health Volunteers Overseas (HVO). HVO is a nonprofit organization that seeks to improve global health through education of the local health workforce in resource-scarce countries. Visit the SSO website to learn more about this exciting partnership.

Share this story:      

SSO 2017 – Register by February 27 for Savings

Mark your calendar for March 15-18, 2017, when SSO will present the 70th Annual Cancer Symposium at the Washington State Convention Center in Seattle, Washington. Register by February 27 for savings!

SSO 2017 program highlights include:

  • Four invited lectures;
  • Two Great Debates sessions covering four controversial topics;
  • 14 symposia sessions covering current controversies, tumor boards and scientific updates;
  • 13 Meet the Professor breakfasts featuring presenters of international prominence leading small-group interactive discussions; and
  • 500+ thought-provoking abstracts covering cutting-edge science and clinical trials, presented over two plenary sessions, nine disease-site parallel sessions, video sessions and more than 400 poster presentations.

Find the latest information and view full details of the SSO 2017 program here.

Share this story:      

SSO 2017 Pre-Meetings Offer a Deeper Dive

Make the most of your SSO 2017 experience by attending a Pre-Meeting Workshop on Wednesday, March 15. Organized by the SSO Scientific Program Committee, Training Committee and Research Committee, Pre-Meeting Workshops are designed to benefit SSO members and SSO 2017 attendees. With an emphasis on practical information for the practicing surgeon, topics include:

A separate registration fee is required and seating is limited. Make the most of your time in Seattle and register now.

SSO, BSSO and ESSO Release International Educational Video

The SSO, the European Society of Surgical Oncology (ESSO) and the Brazilian Society of Surgical Oncology (BSSO) worked in partnership on the production of a video that explains the positive impact of specialized surgery in the fight against cancer. The video highlights the need to invest in surgery research, surgeons' continuing medical education, and encourage innovation in cancer treatments and technology. Watch the video.

2017 Regional Cancer Therapies Symposium Featured Recent Therapy Advances

For the first year in partnership with the SSO, the 12th International Symposium on Regional Cancer Therapies took place February 18-20, 2017 in Snowbird, UT. The three-day program was designed to cover the most recent advances in cancer therapy that are primarily of a regional focus, such as gastrointestinal, intraperitoneal, hepatic, ovarian and thoracic cancers.

Learn more about this event, as well as other educational programs.

SSO 2017-18 Election Results Announced

Based on the results of an e-ballot to SSO members, the Councilor-at-Large and 2017-18 Nominating Committee Members have been selected and are listed below.

Councilor-at-Large:
Jon Zager, MD, Senior Member at Moffitt Cancer Center and Professor of Surgery at the University of South Florida School of Medicine in Tampa, Florida. Dr. Zager is also the Director of Regional Therapies, the Chair of Graduate Medical Education at Moffitt Cancer Center, and the current President of the Medical Staff.


2017-18 Nominating Committee Members:

Community-based Surgical Oncologist Representative
Scott Kurtzman, MD, Professor of Surgery at the University of Connecticut Health Center and Chairman of Surgery and Program Director of the General Surgery Residency Program at Waterbury Hospital, Waterbury Connecticut.

International Surgical Oncologist Representative
Claudio Quadros, MD, Professor of Surgery at Bahia State University's Medical School and Professor and "hands on instructor" of residents in Surgical Oncology at Aristides Maltez Cancer Hospital.

Undesignated Active Member Representative
Doug Evans, MD, Ausman Family Foundation Professor of Surgery and Chair of the Department of Surgery at The Medical College of Wisconsin.

The SSO membership will formally approve the 2017-2018 officers and Executive Council members at SSO 2017 during the annual business meeting held on Saturday, March 18, from 5-5:30 pm in Rooms 602-603 of the Washington State Convention Center.

SSO Membership Growth Sets New Record

SSO membership reaches its highest numbers in history through member retention efforts and growth. SSO ended the year with a record-breaking total of 2,933 members (pre-audit), reflecting a 4.71% increase in membership in 2016.

The fastest area of growth was trainees; in fact, 178 residents and students have joined SSO since the Resident and Medical Student category was introduced in early 2016. Total members in other categories include 1,672 Active, 396 Active International, 350 Emeritus, 319 Candidate, and 18 Associate. In the month of August, more than 40 candidates joined SSO in anticipation of the Fellows Institute that took place in November.

Retention was the focus of the Membership Committee, chaired by Douglas Tyler, MD. The committee implemented an initiative to increase retention in 2016 and succeeded in raising retention rates from 86% to 91%. The Society will apply the most effective communication efforts used in the retention efforts going forward to ensure members are properly informed about their membership status and SSO's educational products.

All SSO members are encouraged to reach out and invite non-member surgeons, physician assistants, nurse practitioners, and healthcare providers in surgical oncology to join the Society. Further, if you have not renewed your membership for 2017, please take a moment to login to the SSO website and renew now so you may continue enjoying exclusive member prices for the Annual Cancer Symposium registration and all other benefits that SSO has to offer. If you need assistance renewing, please contact membership@surgonc.org or call (847) 427-1400, extension 108. SSO staff is happy to assist you with any membership inquiry.

The SSO Foundation Supports Surgical Oncology Research and Education

Generous contributions to The SSO Foundation have enabled the funding of research awards in surgical oncology, including the Clinical Investigator and Young Investigator Awards. Subjects of recently funded research efforts include:

  • Therapeutic Peptide Nanofiber Vaccines Targeting Melanoma,
  • Radiation and Natural Killer Cell Immunotherapy to Target Tumor Heterogeneity in Canine Bone and Soft Tissue Sarcoma,
  • Health Literacy and Cancer Outcomes,
  • Modulation of tumor-promoting influences of y&T cells in pancreatic carcinoma in a Phase II clinical trial utilizing perioperative gemcitabine + nab-paclitaxel, and
  • Identifying Novel Mechanisms of Metastases in Colorectal Cancer.

The SSO Foundation also raises funds from industry and private foundations to support SSO educational programs including the SSO Fellows Institute and the SSO Annual Cancer Symposium. In addition, member contributions are used to underwrite The SSO Foundation lectureships and awards that are presented at the SSO Annual Cancer Symposium including:

  • James Ewing Lecture
  • Harvey Baker Traveling Fellow Award
  • James Ewing Layperson's Award
  • Resident Essay Awards

Join your SSO colleagues by making a donation today. All donors are recognized in SSO publications, on the SSO and The SSO Foundation website and on signage at SSO 2017. Make your tax-deductible gift.

Share this story:      

SSO Programs Offer Complimentary CME/MOC Credit

Earn AMA PRA Category 1 CreditTM and self-assessment credit that may be applied toward Part 2 of the ABS MOC Program by reading the two latest Educational Review Series, “Genomic Markers in the Multidisciplinary Treatment of Cancer” and “What’s New in Gastric and Esophageal Cancers?” and completing a self-assessment exam. Exams may be completed online and are available via your iPad, iPhone or Android devices. Click here to access the review series.

Share this story:      

More Free CME Available by Viewing the DCIS Archived Webinar

An additional opportunity to earn free CME credit is now available online. Earn CME credit by viewing the archived webinar from speakers Monica Morrow, MD, and Meena S. Moran, MD, which covers the joint statement issued from SSO, ASTRO, and ASCO on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Ductal Carcinoma in Situ. This activity is supported by an independent educational grant from Susan G. Komen. View the webinar here.